You will now be redirected to the GD3 website
Ingenio Diagnostics is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3About
Collaboration breeds innovation
Ingenio Diagnostics (ID) combines experience in Pharmaceutical, Biotechnology, and CRO services with a clinical diagnostic laboratory’s licensure and accreditation. We deliver clinical diagnostic laboratory services and specialty testing with the additional benefit of dedicated quality assurance & quality control division. Our highly-skilled team of scientists, clinical, and operations personnel have extensive experience analyzing a wide variety of patient specimen types, spanning multiple analytical platforms in many therapeutic areas.
Testing is performed by laboratories certified by the Clinical Laboratory Improvement Amendments (CLIA) ACT 1988, which the FDA recognizes as satisfactory for diagnostic testing purposes and accredited by the College of American Pathologists (CAP)and under Good Laboratory Practices (GLP) guidelines. Both of which are the industry gold standard in all areas of routine testing to high-complexity esoteric testing of patient and clinical trial samples.
ID offers more than two decades of clinical laboratory excellence with various technologies, platforms, and capabilities to support your clinical studies. We are your trusted partner to advance diagnostic capabilities, assay design, miniaturization, high-throughput testing with a short turnaround time and improve analytical methods through rigorous testing standards to advance your goal of bringing therapies to patients and their physicians. Our Pharmaceutical and Clinical Research members’ knowledge, coupled with the strength our highly accredited, state-of-the-art clinical diagnostic laboratories creates an unparalleled dynamic team.
